{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:49:40Z","timestamp":1780634980750,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Ophthalmol Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s40135-019-00213-0","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T10:02:57Z","timestamp":1563876177000},"page":"171-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Molecular Biomarkers for Glaucoma"],"prefix":"10.1007","volume":"7","author":[{"given":"Gala","family":"Beykin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"issue":"3","key":"213_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"213_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","volume":"109","author":"A Sommer","year":"1991","unstructured":"Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991;109(8):1090\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"213_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working G","year":"2001","unstructured":"Biomarkers Definitions Working G. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89\u201395.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"213_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463\u20136.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"213_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1878-5085-4-7","volume":"4","author":"E Drucker","year":"2013","unstructured":"Drucker E, Krapfenbauer K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J. 2013;4(1):7.","journal-title":"EPMA J"},{"issue":"5","key":"213_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000079477","volume":"218","author":"M Nakabayashi","year":"2004","unstructured":"Nakabayashi M. Review of the ischemia hypothesis for ocular hypertension other than congenital glaucoma and closed-angle glaucoma. Ophthalmologica. 2004;218(5):344\u20139.","journal-title":"Ophthalmologica"},{"key":"213_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fnins.2017.00478","volume":"11","author":"G Chidlow","year":"2017","unstructured":"Chidlow G, Wood JPM, Casson RJ. Investigations into hypoxia and oxidative stress at the optic nerve head in a rat model of Glaucoma. Front Neurosci. 2017;11:478.","journal-title":"Front Neurosci"},{"issue":"2","key":"213_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.exer.2010.07.009","volume":"93","author":"G Tezel","year":"2011","unstructured":"Tezel G. The immune response in glaucoma: a perspective on the roles of oxidative stress. Exp Eye Res. 2011;93(2):178\u201386.","journal-title":"Exp Eye Res"},{"issue":"4\u20135","key":"213_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3109\/08820538.2011.588649","volume":"26","author":"TA Shazly","year":"2011","unstructured":"Shazly TA, Aljajeh M, Latina MA. Autoimmune basis of glaucoma. Semin Ophthalmol. 2011;26(4\u20135):278\u201381.","journal-title":"Semin Ophthalmol"},{"key":"213_CR10","doi-asserted-by":"crossref","unstructured":"Soto I, Howell GR. The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med 2014;4(8). pii: a017269.","DOI":"10.1101\/cshperspect.a017269"},{"key":"213_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.preteyeres.2013.01.004","volume":"35","author":"G Tezel","year":"2013","unstructured":"Tezel G. A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration. Prog Retin Eye Res. 2013;35:18\u201343.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"213_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17116\/oftalma201813404141","volume":"134","author":"TA Pavlenko","year":"2018","unstructured":"Pavlenko TA, Kim AR, Kurina AY, Davydova NG, Kolomojceva EM, Chesnokova NB, et al. Endothelins and dopamine levels in tears for assessment of neurovascular disorders in glaucoma. Vestn oftalmol. 2018;134(4):41\u20136.","journal-title":"Vestn oftalmol"},{"issue":"4","key":"213_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.31288\/oftalmolzh201262025","volume":"129","author":"TA Pavlenko","year":"2013","unstructured":"Pavlenko TA, Chesnokova NB, Davydova HG, Okhotsimskaia TD, Beznos OV, Grigor\u2019ev AV. Level of tear endothelin-1 and plasminogen in patients with glaucoma and proliferative diabetic retinopathy. Vestn oftalmol. 2013;129(4):20\u20133.","journal-title":"Vestn oftalmol"},{"issue":"5","key":"213_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cytogfr.2015.07.007","volume":"26","author":"S Pasquin","year":"2015","unstructured":"Pasquin S, Sharma M, Gauchat JF. Ciliary neurotrophic factor (CNTF): new facets of an old molecule for treating neurodegenerative and metabolic syndrome pathologies. Cytokine Growth Factor Rev. 2015;26(5):507\u201315.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"213_CR15","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1167\/iovs.14-15266","volume":"55","author":"K Flachsbarth","year":"2014","unstructured":"Flachsbarth K, Kruszewski K, Jung G, Jankowiak W, Riecken K, Wagenfeld L, et al. Neural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult mice. Invest Ophthalmol Vis Sci. 2014;55(11):7029\u201339.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"213_CR16","first-page":"799","volume":"23","author":"AA Shpak","year":"2017","unstructured":"\u2022\u2022 Shpak AA, Guekht AB, Druzhkova TA, Kozlova KI, Gulyaeva NV. Ciliary neurotrophic factor in patients with primary open-angle glaucoma and age-related cataract. Mol Vis. 2017;23:799\u2013809 CNTF has been demonstrated in multiple pre-clinical models to enhance survival and regeneration of retinal ganglion cells. A phase 2 randomized clinical trial assessing CNTF as a therapy for glaucoma patients is currently underway ( Clinicaltrials.gov #NCT02862938). In this paper, CNTF concentrations were studied in the aqueous humor (AH), lacrimal fluid (LF), and blood serum of 145 patients to show CNTF concentration is reduced in the AH and LF of patients with POAG, especially in those with severe visual field loss, and that the CNTF concentration in AH and LF strongly correlates. This phenomenon opens up new options for a non-invasive estimation of the CNTF concentration in AH.","journal-title":"Mol Vis"},{"issue":"3","key":"213_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0896-6273(00)80173-7","volume":"17","author":"TL Deckwerth","year":"1996","unstructured":"Deckwerth TL, Elliott JL, Knudson CM, Johnson EM Jr, Snider WD, Korsmeyer SJ. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron. 1996;17(3):401\u201311.","journal-title":"Neuron"},{"issue":"3","key":"213_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017659","volume":"6","author":"MS Gregory","year":"2011","unstructured":"Gregory MS, Hackett CG, Abernathy EF, Lee KS, Saff RR, Hohlbaum AM, et al. Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death. PLoS One. 2011;6(3):e17659.","journal-title":"PLoS One"},{"issue":"4","key":"213_CR19","first-page":"27","volume":"128","author":"OS Slepova","year":"2012","unstructured":"Slepova OS, Frolov MA, Morozova NS, Frolov AM, Lovpache DN. Markers of Fas-mediated apoptosis in primary open-angle glaucoma and opportunities of their pharmacological correction. Vestn oftalmol. 2012;128(4):27\u201331.","journal-title":"Vestn oftalmol"},{"issue":"4","key":"213_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1039\/C1MB05357D","volume":"8","author":"D Pieragostino","year":"2012","unstructured":"Pieragostino D, Bucci S, Agnifili L, Fasanella V, D\u2019Aguanno S, Mastropasqua A, et al. Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma. Mol BioSyst. 2012;8(4):1017\u201328.","journal-title":"Mol BioSyst"},{"issue":"2","key":"213_CR21","first-page":"61","volume":"53","author":"D Borovic","year":"2009","unstructured":"Borovic D, Bendelic E, Chiselita D. Study of kini-kallikrein and renin--angiotensin systems in patients with primary open angle glaucoma. Oftalmologia. 2009;53(2):61\u20138.","journal-title":"Oftalmologia"},{"key":"213_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/1874364101509010028","volume":"9","author":"M Holappa","year":"2015","unstructured":"Holappa M, Valjakka J, Vaajanen A. Angiotensin(1-7) and ACE2, \u201cthe hot spots\u201d of renin-angiotensin system, detected in the human aqueous humor. Open Ophthalmol J. 2015;9:28\u201332.","journal-title":"Open Ophthalmol J"},{"key":"213_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/1874364101711010122","volume":"11","author":"M Holappa","year":"2017","unstructured":"Holappa M, Vapaatalo H, Vaajanen A. Many faces of renin-angiotensin system - focus on eye. Open Ophthalmol J. 2017;11:122\u201342.","journal-title":"Open Ophthalmol J"},{"issue":"6","key":"213_CR24","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1039\/c3mb25463a","volume":"9","author":"D Pieragostino","year":"2013","unstructured":"Pieragostino D, Agnifili L, Fasanella V, D\u2019Aguanno S, Mastropasqua R, Di Ilio C, et al. Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naive to therapy. Mol BioSyst. 2013;9(6):1108\u201316.","journal-title":"Mol BioSyst"},{"issue":"1","key":"213_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exer.2011.10.017","volume":"94","author":"HY Lopilly Park","year":"2012","unstructured":"Lopilly Park HY, Kim JH, Lee KM, Park CK. Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea. Exp Eye Res. 2012;94(1):13\u201321.","journal-title":"Exp Eye Res"},{"issue":"10","key":"213_CR26","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1167\/iovs.10-6532","volume":"52","author":"TT Wong","year":"2011","unstructured":"Wong TT, Zhou L, Li J, Tong L, Zhao SZ, Li XR, et al. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest Ophthalmol Vis Sci. 2011;52(10):7385\u201391.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"213_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/bjo.2006.101485","volume":"91","author":"L Malvitte","year":"2007","unstructured":"Malvitte L, Montange T, Vejux A, Baudouin C, Bron AM, Creuzot-Garcher C, et al. Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br J Ophthalmol. 2007;91(1):29\u201332.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"213_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jtos.2017.03.004","volume":"15","author":"JM Martinez-de-la-Casa","year":"2017","unstructured":"\u2022 Martinez-de-la-Casa JM, Perez-Bartolome F, Urcelay E, Santiago JL, Moreno-Montanes J, Arriola-Villalobos P, et al. Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost. Ocul Surf. 2017;15(4):723\u20139 This paper found 10 of 27 inflammatory cytokines in tear samples of 79 subjects were significantly higher in patients receiving preserved, but not preservative-free latanoprost, compared with normal controls. This highlights the inflammatory effect of preservatives on the ocular surface.","journal-title":"Ocul Surf"},{"issue":"8","key":"213_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201740","volume":"13","author":"S Reddy","year":"2018","unstructured":"Reddy S, Sahay P, Padhy D, Sarangi S, Suar M, Modak R, et al. Tear biomarkers in latanoprost and bimatoprost treated eyes. PLoS One. 2018;13(8):e0201740.","journal-title":"PLoS One"},{"key":"213_CR30","doi-asserted-by":"crossref","unstructured":"Benitez-Del-Castillo J, Cantu-Dibildox J, Sanz-Gonzalez SM, Zanon-Moreno V, Pinazo-Duran MD. Cytokine expression in tears of patients with glaucoma or dry eye disease: a prospective, observational cohort study. Eur J Ophthalmol 2019;29(4):437-43..","DOI":"10.1177\/1120672118795399"},{"issue":"6","key":"213_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1444-0938.2002.tb02384.x","volume":"85","author":"CH To","year":"2002","unstructured":"To CH, Kong CW, Chan CY, Shahidullah M, Do CW. The mechanism of aqueous humour formation. Clin Exp Optom. 2002;85(6):335\u201349.","journal-title":"Clin Exp Optom"},{"key":"213_CR32","first-page":"370","volume":"14","author":"X Duan","year":"2008","unstructured":"Duan X, Lu Q, Xue P, Zhang H, Dong Z, Yang F, et al. Proteomic analysis of aqueous humor from patients with myopia. Mol Vis. 2008;14:370\u20137.","journal-title":"Mol Vis"},{"key":"213_CR33","first-page":"2839","volume":"16","author":"X Duan","year":"2010","unstructured":"Duan X, Xue P, Wang N, Dong Z, Lu Q, Yang F. Proteomic analysis of aqueous humor from patients with primary open angle glaucoma. Mol Vis. 2010;16:2839\u201346.","journal-title":"Mol Vis"},{"key":"213_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.exer.2012.07.011","volume":"103","author":"A Bagnis","year":"2012","unstructured":"Bagnis A, Izzotti A, Centofanti M, Sacca SC. Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma. Exp Eye Res. 2012;103:55\u201362.","journal-title":"Exp Eye Res"},{"issue":"8","key":"213_CR35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3109\/02713683.2011.556299","volume":"39","author":"A Goyal","year":"2014","unstructured":"\u2022 Goyal A, Srivastava A, Sihota R, Kaur J. Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients. Curr Eye Res. 2014;39(8):823\u20139 This paper found a significant increase in superoxide dismutase and glutathione peroxidase activities and a significant decrease in vitamins C and E in 90 aqueous humor samples of POAG and PACG patients compared to control patients, suggesting that a significant increase in oxidative stress may play a role in the pathogenesis of POAG and PACG.","journal-title":"Curr Eye Res"},{"issue":"12","key":"213_CR36","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2217\/bmm-2016-0167","volume":"10","author":"L Canizales","year":"2016","unstructured":"Canizales L, Rodriguez L, Rivera C, Martinez A, Mendez F, Castillo A. Low-level expression of SOD1 in peripheral blood samples of patients diagnosed with primary open-angle glaucoma. Biomark Med. 2016;10(12):1218\u201323.","journal-title":"Biomark Med"},{"issue":"6","key":"213_CR37","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.ajpath.2012.02.030","volume":"180","author":"B Junglas","year":"2012","unstructured":"Junglas B, Kuespert S, Seleem AA, Struller T, Ullmann S, Bosl M, et al. Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork. Am J Pathol. 2012;180(6):2386\u2013403.","journal-title":"Am J Pathol"},{"issue":"1","key":"213_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00441-011-1274-7","volume":"347","author":"R Fuchshofer","year":"2012","unstructured":"Fuchshofer R, Tamm ER. The role of TGF-beta in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 2012;347(1):279\u201390.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"213_CR39","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.19082\/3833","volume":"9","author":"N Khalef","year":"2017","unstructured":"Khalef N, Labib H, Helmy H, El Hamid MA, Moemen L, Fahmy I. Levels of cytokines in the aqueous humor of eyes with primary open angle glaucoma, pseudoexfoliation glaucoma and cataract. Electron Physician. 2017;9(2):3833\u20137.","journal-title":"Electron Physician"},{"key":"213_CR40","doi-asserted-by":"crossref","unstructured":"Ten Berge JC, Fazil Z, van den Born I, Wolfs RCW, Schreurs MWJ, Dik WA, et al. Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract. Acta Ophthalmol 2019;97(2):185-192.","DOI":"10.1111\/aos.13899"},{"issue":"2","key":"213_CR41","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1167\/iovs.13-13591","volume":"55","author":"W Huang","year":"2014","unstructured":"Huang W, Chen S, Gao X, Yang M, Zhang J, Li X, et al. Inflammation-related cytokines of aqueous humor in acute primary angle-closure eyes. Invest Ophthalmol Vis Sci. 2014;55(2):1088\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"213_CR42","doi-asserted-by":"publisher","first-page":"BSR20181411","DOI":"10.1042\/BSR20181411","volume":"38","author":"Y Wang","year":"2018","unstructured":"Wang Y, Chen S, Liu Y, Huang W, Li X, Zhang X. Inflammatory cytokine profiles in eyes with primary angle-closure glaucoma. Biosci Rep. 2018;38(6):BSR20181411.","journal-title":"Biosci Rep"},{"issue":"10","key":"213_CR43","doi-asserted-by":"publisher","first-page":"e0165314","DOI":"10.1371\/journal.pone.0165314","volume":"11","author":"MA Kaeslin","year":"2016","unstructured":"\u2022\u2022 Kaeslin MA, Killer HE, Fuhrer CA, Zeleny N, Huber AR, Neutzner A. Changes to the aqueous humor proteome during glaucoma. PLoS One. 2016;11(10):e0165314 This study found 87 protein differences in patients with glaucoma versus a control group by quantitative proteome analysis of the aqueous humor. Differentially expressed proteins were found to be involved in cholesterol-related, inflammatory, metabolic, and antioxidant as well as proteolysis-related processes.","journal-title":"PLoS One"},{"issue":"6","key":"213_CR44","first-page":"925","volume":"10","author":"Y Tong","year":"2017","unstructured":"Tong Y, Zhou YL, Zheng Y, Biswal M, Zhao PQ, Wang ZY. Analyzing cytokines as biomarkers to evaluate severity of glaucoma. Int J Ophthalmol. 2017;10(6):925\u201330.","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"213_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12858-7","volume":"7","author":"M Mirzaei","year":"2017","unstructured":"Mirzaei M, Gupta VB, Chick JM, Greco TM, Wu Y, Chitranshi N, et al. Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Sci Rep. 2017;7(1):12685.","journal-title":"Sci Rep"},{"issue":"8","key":"213_CR46","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3181\/0811-RM-344","volume":"234","author":"MM Walsh","year":"2009","unstructured":"Walsh MM, Yi H, Friedman J, Cho KI, Tserentsoodol N, McKinnon S, et al. Gene and protein expression pilot profiling and biomarkers in an experimental mouse model of hypertensive glaucoma. Exp Biol Med. 2009;234(8):918\u201330.","journal-title":"Exp Biol Med"},{"issue":"1","key":"213_CR47","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/s41467-018-05681-9","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Cho KS, Vu THK, Shen CH, Kaur M, Chen G, et al. Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun. 2018;9(1):3209.","journal-title":"Nat Commun"},{"key":"213_CR48","first-page":"1260","volume":"16","author":"KN Engin","year":"2010","unstructured":"Engin KN, Yemisci B, Yigit U, Agachan A, Coskun C. Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol Vis. 2010;16:1260\u201371.","journal-title":"Mol Vis"},{"key":"213_CR49","volume":"2015","author":"X Luo","year":"2015","unstructured":"Luo X, Shen YM, Jiang MN, Lou XF, Shen Y. Ocular blood flow autoregulation mechanisms and methods. J Ophthalmol. 2015;2015:864871.","journal-title":"J Ophthalmol"},{"issue":"4","key":"213_CR50","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1167\/iovs.11-8420","volume":"53","author":"S Javadiyan","year":"2012","unstructured":"Javadiyan S, Burdon KP, Whiting MJ, Abhary S, Straga T, Hewitt AW, et al. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma. Invest Ophthalmol Vis Sci. 2012;53(4):1923\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"213_CR51","first-page":"67","volume":"130","author":"TN Malishevskaia","year":"2014","unstructured":"Malishevskaia TN, Dolgova IG. Options for correction of endothelial dysfunction and oxidative stress in patients with primary open-angle glaucoma. Vestn oftalmol. 2014;130(5):67\u201370 2-3.","journal-title":"Vestn oftalmol"},{"issue":"5","key":"213_CR52","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IJG.0b013e3181b4cac7","volume":"19","author":"P Huang","year":"2010","unstructured":"Huang P, Qi Y, Xu YS, Liu J, Liao D, Zhang SS, et al. Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma. J Glaucoma. 2010;19(5):324\u201330.","journal-title":"J Glaucoma"},{"issue":"2","key":"213_CR53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/02713683.2017.1396617","volume":"43","author":"AA Shpak","year":"2018","unstructured":"Shpak AA, Guekht AB, Druzhkova TA, Kozlova KI, Gulyaeva NV. Brain-derived neurotrophic factor in patients with primary open-angle Glaucoma and age-related cataract. Curr Eye Res. 2018;43(2):224\u201331.","journal-title":"Curr Eye Res"},{"issue":"4","key":"213_CR54","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/ene.13553","volume":"25","author":"A Tejeda-Velarde","year":"2018","unstructured":"Tejeda-Velarde A, Costa-Frossard L, Sainz de la Maza S, Carrasco A, Espino M, Picon C, et al. Clinical usefulness of prognostic biomarkers in optic neuritis. Eur J Neurol. 2018;25(4):614\u20138.","journal-title":"Eur J Neurol"}],"container-title":["Current Ophthalmology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40135-019-00213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40135-019-00213-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40135-019-00213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T11:18:22Z","timestamp":1664018302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40135-019-00213-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1007\/s40135-019-00213-0","relation":{},"ISSN":["2167-4868"],"issn-type":[{"value":"2167-4868","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"assertion":[{"value":"23 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}